The virulence of two virus clones (HV cl-I and HV cl-2) of Hantaan virus, which were plaque-purified on Vero E6 cells, were compared in suckling mice infected by the intraperitoneal or intracerebral route. HV cl-1 increased the mortality of the mice whereas HV cl-2 did not. Furthermore, virus of high titre was isolated from various organs of mice infected with HV cl-1 and high titres were maintained, whereas after infection with HV cl-2, virus was isolated from various organs only in low titre and only temporarily. HV cl-1 strongly induced cell-to-cell fusion, but the cell fusion activity was at a minimum level in cells infected with HV cl-2. However these two clones induced similar titres of antibodies in mice. Cytotoxic T lymphocyte assays against macrophages infected with homologous and heterologous virus showed that cytotoxic T cell activity was induced in mice infected with HV cl-2, but suppressed in mice infected with HV cl-1. These results suggest that an alteration in the cell fusion function and the cytotoxic T cell activity are important in the pathogenesis of Hantaan virus infection in newborn mice.
INTRODUCTION
Hantaviruses, which cause haemorrhagic fever with renal syndrome (HFRS), are widely distributed throughout the world and affect humans (Gajdusek, 1962; Lahdevirta, 1982; Lee, 1978) . Hantaan virus (HV), which is the aetiological agent of Korean haemorrhagic fever, was first isolated in 1976 from Apodemus agrarius coreae (Lee et al., 1978) . Subsequently, several viruses that are antigenically related to HV were isolated from rodents and humans (Kitamura et al., 1983; Lee et al., 1982a, b; Niklasson et al., 1984; Song et al., 1983; Yamanishi et al., 1983; Yanagihara et al., 1984) . Serological and virological findings have established the presence of Hantaan-like viruses in rodents throughout the world. However, the biology of these viruses in chronically infected rodents is poorly understood. For several years efforts have been made to develop an animal model for use in studies on the mechanism of the disease in both humans and rodents. Newborn laboratory mice have been found to be susceptible to infection with hantaviruses Kurata et al., 1983b; McKee et al., 1985; Tsai et al., 1982; Yamanouchi et al., 1984) . When HV was inoculated into newborn mice, the animals showed various clinical symptoms and finally died. However, HV has the potential to undergo changes in biological properties, and a decrease in its virulence has been observed during passages in. Vero E6 cells (K. Yamanishi et al., unpublished data) . Therefore, we isolated viral clones by plaque assay and studied their pathogenicity in mice. In the present study, the biological characteristics of two representative clones (HV cl-1 and HV cl-2) were examined in mice and in vitro. The mechanism of virulence is discussed.
Cells. Veto E6 cells were obtained from the American Type Culture Collection and cultured in growth medium consisting of Eagle's MEM supplemented with 5 ~ foetal calf serum (FCS), or in maintenance medium which had the same composition except that it contained 3~ FCS.
Virus and infectivity assay. The 76-118 strain of HV, originally isolated from Apodemus mouse lung (Lee et al., 1978) and then passaged four times in A549 cells and 16 times in Vero E6 cells, was obtained from the ATCC. The 76-118 strain was passaged twice more in our laboratory before use in preparation of virus stock.
Test virus suspensions were diluted with growth medium, introduced onto cell monolayers in 60 mm plastic plates and allowed to become adsorbed for 1 h at 37 °C in a humid atmosphere of 5 ~ CO2 in air. The monolayers were then washed with phosphate-buffered saline (PBS), and 5 ml of Eagle's MEM containing 10 ~ FCS and 0.8 % purified agar (Difco) was added to each plate. After incubation at 37 °C for 7 days, the monolayers were stained by the addition of a 5 ml layer of 0.8 ~ purified agar, plus Eagle's MEM with 0.2 ~ bovine serum albumin containing 20 mM-HEPES and 20 mM-MES buffer (adjusted to the appropriate pH with 0-5 M-NaOH), and 0.006~ neutral red. The plates were then returned to the incubator and plaques were counted 3 days later.
Isolation of variants byplaque assay. The virus was harvested from well separated plaques by plunging a Pasteur pipette into the agar directly over the plaque. For selected clones, this process was repeated twice without intermediate amplification. The virus was then dispersed in 1 ml of medium and frozen at -70 °C.
Mice and virus inoculation. BALB/c mice (H-2 d) of 6 to 8 weeks old were obtained from CLEA Japan. The virus was inoculated intracerebrally (i.c.) or intraperitoneally (i.p.) into suckling mice within 24 h after birth. Mice similarly inoculated with medium served as controls. The mortality and clinical symptoms of the mice were recorded for 6 weeks after the inoculation.
Two animals were sacrificed at 2 to 3 day intervals from days 4 to 22 after infection. The brain, lungs, spleen and kidneys were excised aseptically and cut in half. One half of each organ was placed in 10 ~ buffered formalin for detection of viral antigen. The other half was homogenized in 9 volumes of PBS, the homogenate was centrifuged at 2000 r.p.m, for 20 min at 4 °C, and the supernatant was stored at -70 °C until analysis by plaque titration.
Viralgrowth in Veto E6 cells. Confluent monolayers of Vero E6 cells in 60 mm Petri dishes were infected with HV cl-1 or HV cl-2 at an m.o.i, of 0.1 p.f.u./cell. After adsorption of virus for 1 h at 37 °C, the cells were washed and fed with 5 mi of medium. Portions of 0.3 ml cell suspension were collected daily, and stored at -70 °C until assayed. The volume of the cultures was made up each time by adding fresh medium in place of the sample.
Viral growth in peritoneal exudate cells (PECs).
PECs were collected from newborn mice without previous stimulation by washing their peritoneal cavity with RPMI 1640 medium supplemented with 10 ~ FCS. The liquid was removed by aspiration and introduced into plastic chambers. After overnight incubation at 37 °C in a CO2 incubator, non-adherent cells were removed and adherent cells were washed three times with RPMI 1640 medium. The number of these adherent cells, referred to as macrophages, was determined by direct counts on selected fields with an inverted microscope. Then the cells were infected with virus at an m.o.i, of 0.1 p.f.u./cell. After virus adsorption for 1 h at 37 °C, the cells were washed and fed with 1.5 ml of medium. Samples of 0-3 ml cell suspension were collected daily.
Celt fusion assay. Confluent monolayers of Vero E6 cells in two-chamber plates (Miles Laboratories) were infected with HV cl-1 or HV cl-2 at an m.o.i, of 0.01 p.f.u./cell, kept at 37 °C for I h, washed and fed with medium.
At 7 days after infection the ceils were washed with PBS, exposed to prewarmed (37 °C) MEM with HEPES (20 mM) and MES (20 mM) adjusted to pH 5-5 with NaOH for 1 h. After exposure to a low pH the cells were returned to pH 7.5 and incubated at 37 °C for 6 h. The cells were then fixed and stained with haematoxylin and eosin.
Preparation ofmacrophages as target cells. PECs were obtained by washing the peritoneal cavity with cold Eagle's MEM supplemented with 10~ FCS, penicillin, streptomycin and L-glutamine. After incubation for 3 h in 60 mm Petri dishes at 37 °C, non-adherent cells were removed. Then the adherent cells were inoculated with virus at an m.o.i, of 0.5 p.f.u./cell. The cells were incubated at 37 °C for 2 h, washed and cultured in fresh medium for 5 days. At this time all the cells contained viral antigen, as shown by the immunofluorescence (IF) technique. The virus-infected macrophages were treated with 0.02% EDTA in PBS at 4 °C for 30 rain and removed from dishes. They were then washed and labelled with 100 ~tCi per 106 cells of s lCr (sodium chromate in saline) for 1 h. They were then washed three times and resuspended at a concentration of 105 cells/ml in RPMI 1640 supplemented with 10% heat-inactivated FCS, L-glutamine, penicillin and 2-mercaptoethanol (complete RPMI). Uninfected macrophages were labelled simultaneously.
Immunization of mice and preparation of spleen cells. Newborn or 6-week-old mice were infected i.p. with 1 × 104 p.f.u, of one of the virus preparations. Two weeks after infection, their spleens were removed aseptically. The spleen cells were treated with 0.83 ~ NH4C1 solution to remove erythrocytes, washed and resuspended in complete RPMI medium. For in vitro stimulation, 1 x 107 spleen cells were cultured with 5 x 105 infected macrophages at 37 °C for 5 days under 5% CO2 in air. The infected macrophages were prepared in the same way as target cells.
Cytotoxic Tlymphocyte (CTL) assay. The CTL assay was performed as described previously (Asada et al., 1987) . Briefly, 51Cr-labelled target cells were added to the wells of U-shaped microtitre plates (104 ceils per well in 100 ~tl of complete RPMI medium). The number of viable effector cells was counted and then the cells were suspended in complete RPMI medium and 100 ~tl volumes were introduced into microtitre plates. The microtitre plates were centrifuged at 1000 r.p.m, for 30 s before incubation. CTL assays at different effector-to-target ratios were carried out in triplicate. The microtitre plates were incubated under 5 ~o COz in air at 37 °C for 4 h, and then centrifuged at 1500 r.p.m, for 5 rain and 50 ~tl samples of the supernatants were counted in a gamma counter. The percentage specific s~Cr release was calculated as (experimental release -spontaneous release)/(total release -spontaneous release). The total release was determined after exposing target cells to 3~o Triton-X 100.
Detection ofviralantigen. Tissues were fixed in 10~ buffered formalin solution for 7 to 10 days and embedded in paraffin. Then, sections of 4 p.m were cut, deparaffinized, treated with 0.25 ~ trypsin and stained by the indirect IF method using convalescent phase human sera from patients with typical Korean haemorrhagic fever as described elsewhere (Kurata et al., 1983a) . Anti-human IgG goat serum-conjugated fluorescein isothiocyanate was purchased from Wellcome.
Haemagglutination-inhibition (HI) test. The preparation of haemagglutination antigen and procedures for the HI test have been described previously (Okuno et al., 1986) .
RESULTS

Pathogenesis of the two variants (HV cl-1 and HV cl-2) in newborn mice
In the present experiment, we picked 20 clones from well separated plaques and each cloned virus was inoculated first to suckling mice. Since most clones were virulent like the parental virus, we selected two clones (HV cl-1 and HV cl-2) as representatives differing in virulence in mice. Before the various assays, we confirmed that these two clones were HV by crossneutralization, protein analysis using SDS-PAGE after immunoprecipitation and the reactivity with monoclonal antibodies which were isolated previously (Yamanishi et al., 1985) . Groups consisting of two litters of suckling mice (18 mice) were treated i.p. with 0.05 ml of virus suspension (3.8 × 103 p.f.u./mouse or 3.8 x 102 p.f.u./mouse) (Fig. 1 a) or i.c. with 0.01 ml of a suspension of HV cl-1 (7.5 x 102 p.f.u./mouse) (Fig. 1 b) . The mortality and clinical symptoms of the mice were recorded for 40 days after virus inoculation. Mice infected with HV cl-1 i.p. or i.c. exhibited hyperactivity, a symptom of the disease, 10 to 12 days after infection; by 2 weeks after infection the mice had ruffled coats, hunched postures and diminishing mobility. Mice usually started to die by day 8 after i.p. infection (Fig. 1 a) and by day 15 after i.c. infection (Fig. 1 b) . The survival rates of mice infected with HV cl-1 at 3.8 x 103 p.f.u./mouse and 3-0 x 102 p.f.u./mouse by the i.p. route were 22.2~ and 50-0~, respectively. After infections with the virus at 7.5 x 102 p.f.u./mouse and 7.5 x 10 p.f.u./mouse by the i.c. route, the survival rates were 22.2~ and 33.3 ~, respectively; mice infected with HV cl-2 by either the i.p. or i.c. route showed no clinical symptoms and all survived.
Virus isolation from various organs of mice
Newborn mice were infected i.p. with HV cl-1 or HV cl-2 and the virus titres in their brain, lungs, spleen and kidneys were determined at intervals between day 4 and 22 after infection as described in Methods. After infection with H¥ cl-1, the virus titres in the brain, lungs, spleen and kidneys started to increase within 6 days and reached maxima (approximately, 105 p.f.u./ml) on day 10 in the lungs, spleen and kidneys, and on day 14 in the brain. In contrast, after infection with HV cl-2, virus was only transiently detectable at low titre in the brain, lungs, spleen and kidneys (Fig. 2) .
Detection of viral antigen
After inoculation of HV cl-1, viral antigens were first detected in mice by IF on day 16. Specific fluorescence was observed in the neurons of the cerebrum, thalamus and pons, choroid plexus, meninges and spinal cord. The vascular endothelial cells in all these areas had viral antigens (photographs not shown). The antigens were diffusely distributed in the brain in the late stage of infection (days 20 to 22). In the other organs, specific fluorescence was detected in the alveolar and interstitial areas of the lungs, and in the vascular endothelia of the spleen and lymph nodes. Specific fluorescence appeared in the central nervous system in a manner similar to the above, but not in the other organs. After infection with HV cl-2, no viral antigen was detected in any organ within 22 days.
Antibody response
HI antibody titres were estimated in mice infected with one of the viruses. After infection with either virus, HI antibody appeared by day 14 to 16 and increased gradually until day 40 after infection. There was no substantial difference in the antibody responses to the two viruses.
Characteristics of the two viruses in vitro
When the two viruses were inoculated onto Vero E6 cells, plaques were formed at both 39 °C and 37 °C, and did not differ in size at the two temperatures. Measurements of the virus titres of infected Vero E6 between day 1 and day 11 after infection showed that both viruses started to grow by day 3 and that their titres were maximal on day 5 with no difference in the two growth curves (Fig. 3a) .
Next, virus growth in PECs collected from suckling mice was tested. No difference was found in the growth of the two viruses in infected ceils (Fig. 3 b) . Fig. 4 . Cell-cell fusion caused by HV cl-1 (a) and HV cl-2 (b). Vero E6 cells were infected with virus at an m.o.i, of 0.01 p.f.u./cell and incubated. On day 7 after infection, the monolayers were washed with PBS, exposed to low pH (5.5) for 1 h, and incubated at pH 7.5 for 6 h at 37 °C.
Appearance of cell fusion
It has been described that hantaviruses cause cell-to-cell fusion under acidic conditions (Arikawa et al., 1985) . In our assay, the fusion process required exposure to pH 5.5 followed by a return to pH 7.5 conditions. The cell fusion activity was assayed using both viruses. Fusion of cells with HV cl-1 occurred 30 min after the pH was returned to pH 7-5, and the maximal fusion was obtained 6 h later. The fusion efficiency of HV cl-1 was higher than that of HV cl-2 (Fig. 4) .
Assay of CTL
First, spleen cells from adult mice infected with HV cl-1 or HV cl-2 were cultured with macrophages infected with homologous virus. After in vitro stimulation for 5 days, spleen cells were used for cytotoxicity assays against macrophages infected with homologous and heterologous virus. Cytotoxic activity was observed with effector cells from mice infected with HV cl-2, the degree of cytotoxicity being correlated with the effector-to-target cell ratio. In contrast, specific cytotoxic activity was observed at only a low level in mice infected with HV cl-1 (Fig. 5) . 
DISCUSSION
We have described the clinical features of the lethal disease in outbred ICR newborn mice resulting from infection with the 76-118 strain of HV obtained from the ATCC and passaged in Vero E6 cells only a few times (Yamanouchi et al., 1984) . However, when the virus was passaged in Vero E6 cells up to 20 times and virus was inoculated to mice, almost all mice survived, even though high titred virus was inoculated (data not shown). Therefore, we considered that the virulence of HV had changed during its passage in Vero E6 cells, before the plaque-cloning was carried out. In the present experiments, we chose two clones (HV cl-1 and -2) differing in virulence in mice. Either i.p. or i.c. infection with HV cl-1 resulted in high mortality, but infection with HV cl-2 caused no substantial difference in the mortality rate of infected and control mice. These data suggest that not all virions in the original stock virus possess the determinants of virulence, and that the virulence of a virus population may decrease during serial passage in vitro. This is consistent with the report of Holland et al. (1982) that RNA viruses consist of a heterogeneous, continuously evolving population of virions.
Various factors have been reported to determine virulence, such as temperature sensitivity (Mires et al., 1984) , defective interfering particles (Huang, 1977) , cleavage of glycoprotein (Tashiro et al., 1983) and tissue tropism (Field, 1982) . In our experiments, no difference was found in the size or shape of plaques caused by HV cl-1 and HV cl-2, nor in their growth in Vero E6 cells and PECs of mice. Since temperature sensitivity determines the virulence of some viruses (Ghendon et al., 1973; McCahon et al., 1981; Mackenzie, 1975; Mills et al., 1971; Murphy et al., 1972; Preble et al., 1975 ; Zygraich et al., 1973) , plaque assays were carried out at high and normal temperatures. However no difference was found in viral growth of two variants at these different temperatures. As for the fusion activity, HV cl-2 showed decreased fusion activity compared with HV cl-1. It was of interest that HV cl-2, which was not virulent in mice, demonstrated the reduced fusion activity. Since the fusion activity correlates with viral glycoprotein, our result suggests that the viral glycoprotein of these two viruses may be expressed differently in infected cells. A similar correlation between fusion efficiency and virulence has been reported for La Cross virus; an avirulent variant with defective fusion function (GonzalezScarano et al., 1985) . They demonstrated that the external virion protein for the cell fusion activity is important in determining virulence. In our experiment, we could not demonstrate cell-to-cell fusion caused by cell absorption by adaptation of the method of Gonzalez-Scarano et al. (1985) . These data suggest that the fusion is caused by fusion within rather than fusion mediated by virus particles adhering to the cell membrane.
After infection with HV cl-1, virus could be isolated from various organs of mice for a long time. However, after infection with HV cl-2, virus was isolated only transiently at low titre and became undetectable after 10 days in the lung and kidney and after 14 to 16 days in the brain and spleen (Fig. 2) . Since natural killer cells appear 3 to 4 weeks after birth (Herberman, 1975) , another mechanism must cause elimination of virus from these organs. In the case of lymphocytic choriomeningitis virus (LCMV), virus variants selectively suppress LCMVspecific CTL responses and cause persistent infections in immunocompetent mice (Ahmed et al., 1984) . T cells are reported to play a crucial role in resistance of mice to fatal Hantaan virus infection (Asada et al., 1987; Nakamura, 1985a, b) . We have previously reported that CTL, which were generated when spleen cells from mice infected with HV were stimulated in vitro with syngeneic cells infected with viruses, were H-2-restricted, had Lyt 2 + L3T4-markers on their surface and did not lyse uninfected cells (Asada et al., 1987) . Nakamura et al. (1985b) reported that clinical disease and mortality were strongly correlated with virus titres in excess of 10 S p.f.u./0.2 ml of brain suspension. In our experiments, the virus titre in mouse brain infected with HV cl-1 was approx. 105 p.f.u./0.2 ml and that of HV cl-2 was about 102 p.f.u./0.2 ml. Although it is difficult to conclude definitely from our data which were derived using limited numbers of clones, our experiments may suggest that HV cl-1 can replicate easily and cause severe symptoms because it suppresses the specific CTL response (Fig. 5) .
Both of these viruses could infect the macrophages in which they primarily grow (Nagai et al., 1985) , and consequently both viruses induced an antibody response. We described that viral antigen was detected in the endothelial cells of almost all organs of mice which were infected with HV cl-1. If this virus replicates in macrophages, and then attaches to endothelial cells and finally spreads to systemic organs, it is possible that HV cl-1 replicates in endothelial cells and spreads easily in systemic organs, since no specific CTL response to HV cl-1 is induced. However, HV cl-2 may spread only with difficulty in systemic organs by virtue of its altered fusion function. From these findings, the external virion proteins, which correlate with fusion function, seem to relate to the specific CTL response. We showed that fusion function and the CTL activity may be important in determining virulence.
Although genetic studies are required to elucidate the difference between these two variants, HV cl-1 and HV cl-2 will be useful for determining fundamental aspects of the pathogenesis of hantavirus group viruses, rather than for use in the development of a realistic model of human HFRS.
